The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Micha Acopiado has been diagnosed with a stage 3 brain tumour after her partner noticed an odd symptom, as her work friends ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...